Nevro Corp Overview
Pro stress-test →Nevro Corp is a medical device company whose key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. The company was acquired by Globus Medical, a leading musculoskeletal technology company, with the acquisition completed on April 3, 2025.
Strategic Profile
Pro stress-test →The Senza SCS system generates electrical impulses to relieve pain, is implanted by physicians and controlled by patients. The acquisition expanded Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity in neuromodulation and spinal cord stimulation therapies.
Competitive Landscape
Pro stress-test →In the spinal cord stimulation market, Nevro competed with Boston Scientific, Abbott, and emerging innovators in neuromodulation. Its 10 kHz proprietary HF10 therapy provided clinical differentiation in the chronic pain treatment space.
Industry Context
Nevro Corp operates in Medical Devices - Neuromodulation & Spinal Cord Stimulation.
Key facts
Founded: 2006 · Headquarters: Redwood City, CA, United States · Revenue: $408.52 million (last reported annual revenue)